Dramatic Aggregation of Alzheimer Aβ by Cu(II) is Induced by Conditions Representing Physiological Acidosis
Craig S. Atwood,Robert D. Moir,Xudong Huang,Richard C. Scarpa,N. Michael E. Bacarra,Donna M. Romano,Mariana A. Hartshorn,Rudolph E. Tanzi,Ashley I. Bush
DOI: https://doi.org/10.1074/jbc.273.21.12817
IF: 5.485
1998-01-01
Journal of Biological Chemistry
Abstract:The cortical deposition of Aβ is an event that occurs in Alzheimer's disease, Down's syndrome, head injury, and normal aging. Previously, in appraising the effects of different neurochemical factors that impact upon the solubility of Aβ, we observed that Zn2+ was the predominant bioessential metal to induce the aggregation of soluble Aβ at pH 7.4 in vitro and that this reaction is totally reversible with chelation. We now report that unlike other biometals tested at maximal biological concentrations, marked Cu2+-induced aggregation of Aβ1–40 emerged as the solution pH was lowered from 7.4 to 6.8 and that the reaction was completely reversible with either chelation or alkalinization. This interaction was comparable to the pH-dependent effect of Cu2+ on insulin aggregation but was not seen for aprotinin or albumin. Aβ1–40 bound three to four Cu2+ ions when precipitated at pH 7.0. Rapid, pH-sensitive aggregation occurred at low nanomolar concentrations of both Aβ1–40 and Aβ1–42 with submicromolar concentrations of Cu2+. Unlike Aβ1–40, Aβ1–42was precipitated by submicromolar Cu2+ concentrations at pH 7.4. Rat Aβ1–40 and histidine-modified human Aβ1–40 were not aggregated by Zn2+, Cu2+, or Fe3+, indicating that histidine residues are essential for metal-mediated Aβ assembly. These results indicate that H+-induced conformational changes unmask a metal-binding site on Aβ that mediates reversible assembly of the peptide. Since a mildly acidic environment together with increased Zn2+ and Cu2+ are common features of inflammation, we propose that Aβ aggregation by these factors may be a response to local injury. Cu2+, Zn2+, and Fe3+ association with Aβ explains the recently reported enrichment of these metal ions in amyloid plaques in Alzheimer's disease. The cortical deposition of Aβ is an event that occurs in Alzheimer's disease, Down's syndrome, head injury, and normal aging. Previously, in appraising the effects of different neurochemical factors that impact upon the solubility of Aβ, we observed that Zn2+ was the predominant bioessential metal to induce the aggregation of soluble Aβ at pH 7.4 in vitro and that this reaction is totally reversible with chelation. We now report that unlike other biometals tested at maximal biological concentrations, marked Cu2+-induced aggregation of Aβ1–40 emerged as the solution pH was lowered from 7.4 to 6.8 and that the reaction was completely reversible with either chelation or alkalinization. This interaction was comparable to the pH-dependent effect of Cu2+ on insulin aggregation but was not seen for aprotinin or albumin. Aβ1–40 bound three to four Cu2+ ions when precipitated at pH 7.0. Rapid, pH-sensitive aggregation occurred at low nanomolar concentrations of both Aβ1–40 and Aβ1–42 with submicromolar concentrations of Cu2+. Unlike Aβ1–40, Aβ1–42was precipitated by submicromolar Cu2+ concentrations at pH 7.4. Rat Aβ1–40 and histidine-modified human Aβ1–40 were not aggregated by Zn2+, Cu2+, or Fe3+, indicating that histidine residues are essential for metal-mediated Aβ assembly. These results indicate that H+-induced conformational changes unmask a metal-binding site on Aβ that mediates reversible assembly of the peptide. Since a mildly acidic environment together with increased Zn2+ and Cu2+ are common features of inflammation, we propose that Aβ aggregation by these factors may be a response to local injury. Cu2+, Zn2+, and Fe3+ association with Aβ explains the recently reported enrichment of these metal ions in amyloid plaques in Alzheimer's disease. Aβ, a low molecular weight (39–43 amino acids) protein that is a proteolytic product derived from the larger amyloid precursor protein (1Kang J. Lemaire H.G. Unterbeck A. Salbaum J.M. Masters C.L. Grzeschik K.-H. Multhaup G. Beyreuther K. Muller-Hill B. Nature. 1987; 325: 733-736Crossref PubMed Scopus (3789) Google Scholar, 2Goldgaber D. Lerman M.I. McBride O.W. Saffioti U. Gajdusek D.C. Science. 1987; 235: 877-880Crossref PubMed Scopus (1104) Google Scholar, 3Tanzi R.E. Gusella J.F. Watkins P.C. Bruns G.A. St George-Hyslop P. Van Keuren M.L. Patterson D. Pagan S. Kurnit D.M. Neve R.L. Science. 1987; 235: 880-884Crossref PubMed Scopus (1307) Google Scholar), is the major component of neocortical amyloid collections in Alzheimer's disease (AD 1The abbreviations used are: AD, Alzheimer's disease; DS, Down's syndrome; DEPC, diethyl pyrocarbonate; Tricine,N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; MES, 4-morpholineethanesulfonic acid; BSA, bovine serum albumin.; see Refs. 4Maury C.P.J. Lab. Invest. 1995; 72: 4-16PubMed Google Scholar and 5Multhaup G. Beyreuther K. Muller-Hill B. Nature. 1987; 325: 733-736Crossref PubMed Scopus (4151) Google Scholar). As is the case with other amyloid proteins, Aβ originates as a normally soluble and constitutive protein found in biological fluids and tissue (6Shoji M. Golde T. Ghiso J. Cheung T.T. Estus S. Shaffer L.M. Cai X.D. McKay D.M. Tintner R. Frangione B. Younkin S.G. Science. 1992; 258: 126-129Crossref PubMed Scopus (1334) Google Scholar, 7Haass C. Schlossmacher M. Hung A. Vigo-Pelfrey C. Mellon A. Ostaszewski B.L. Lieberburg I. Koo E.H. Schenk D. Teplow D.B. Selkoe D.S. Nature. 1992; 359: 322-325Crossref PubMed Scopus (1832) Google Scholar, 8Seubert P. Vigo-Pelfrey C. Esch F. Nature. 1992; 359: 325-327Crossref PubMed Scopus (1666) Google Scholar, 9Tabaton M. Nunzi M.G. Xue R. Usiak M. Autilio-Gambetti L. Gambetti P. Biochem. Biophys. Res. Commun. 1994; 200: 1598-1603Crossref PubMed Scopus (134) Google Scholar, 10Koudinov A. Matsubara E. Frangione B. Ghiso J. Biochem. Biophys. Res. Commun. 1994; 205: 1164-1171Crossref PubMed Scopus (136) Google Scholar, 11Nakamura T. Shoji M. Harigaya Y. Watanabe M. Hosoda K. Cheung T.T. Shaffer L.M. Golde T.E. Younkin L.H. Younkin S.G. Hirai S. Ann. Neurol. 1994; 36: 903-911Crossref PubMed Scopus (98) Google Scholar, 12Motter R. Vigo-Pelfrey C. Kholodenko M.S. Barbour B.S. Johnson-Wood K. Galasko D. Chang L. Miller B. Clark C. Green R. Olsen D. Southwick P. Wolfert R. Munroe B. Lieberburg I. Seubert P. Schenk D. Ann. Neurol. 1995; 38: 643-648Crossref PubMed Scopus (649) Google Scholar, 13Nitsch R.M. Rebeck G.W. Deng M. Richardson U.I. Tennis M. Schenk D.B. Vigo-Pelfrey C. Lieberburg I. Wurtman R.J. Hyman B.T. Growdon J.H. Ann. Neurol. 1995; 37: 512-518Crossref PubMed Scopus (116) Google Scholar, 14Southwick P.C. Yamagata S.K. Echols Jr., C.L. Higson G.J. Neynaber S.A. Parson R.E. Munroe W.A. J. Neurochem. 1996; 66: 259-265Crossref PubMed Scopus (91) Google Scholar, 15Ida N. Hartmann T. Pantel J. Schroder J. Zerfass R. Forstl H. Sandbrink R. Masters C.L. Beyreuther K. J. Biol. Chem. 1996; 271: 22908-22914Abstract Full Text Full Text PDF PubMed Scopus (474) Google Scholar). Aβ also aggregates to form diffuse amorphous deposits in AD but also following head injury (16Roberts G.W. Gentleman S.M. Lynch A. Graham D.I. Lancet. 1991; 338: 1422-1423Abstract PubMed Scopus (432) Google Scholar, 17Roberts G.W. Gentleman S.M. Lynch A. Murray L. Landon M. Graham D.I. J. Neurol. Neurosurg. Psychiatry. 1994; 57: 419-425Crossref PubMed Scopus (514) Google Scholar, 18Graham D.I. Gentleman S.M. Lynch A. Roberts G.W. Neuropathol. Appl. Neurobiol. 1995; 21: 27-34Crossref PubMed Scopus (136) Google Scholar) and in healthy aged individuals (19Mackenzie I. J. Neuropathol. Exp. Neurol. 1993; 156: 437-442Google Scholar). Combined with other inflammatory proteins such as proteoglycans (20Snow A.D. Sekiguchi R. Nochlin D. Fraser P. Kimata K. Mizutani A. Arai M. Schreier W.A. Morgan D.G. Neuron. 1994; 12: 219-234Abstract Full Text PDF PubMed Scopus (283) Google Scholar), amyloid P-component (21Coria F. Castanño E. Prelli F. Larrondo-Lillo M. van Duinen S. Shelanski M.L. Frangione B. Lab. Invest. 1988; 58: 454-458PubMed Google Scholar), and apolipoprotein E (22Chan W. Fornwald J. Brawner M. Wetzel R. Biochemistry. 1996; 35: 7123-7130Crossref PubMed Scopus (61) Google Scholar, 23Prior R. Durso D. Frank R. Prikulis I. Cleven S. Ihl R. Pavlakovic G. Am. J. Pathol. 1996; 148: 1749-1756PubMed Google Scholar), Aβ is found in the brains of individuals affected by AD and Down's syndrome (DS) as dense extracellular deposits of twisted β-pleated sheet fibrils in the neuropil (senile plaques) and within cerebral blood vessels (amyloid congophilic angiopathy; see Refs. 4Maury C.P.J. Lab. Invest. 1995; 72: 4-16PubMed Google Scholar and 5Multhaup G. Beyreuther K. Muller-Hill B. Nature. 1987; 325: 733-736Crossref PubMed Scopus (4151) Google Scholar). The deposition of Aβ, however, is not confined to the brain parenchyma, having been detected in amyloid diseases of the muscle (24Askanas V. Engel W.K. Curr. Opin. Rheumatol. 1993; 5: 732-741Crossref PubMed Scopus (82) Google Scholar, 25Murakami N. Ihara Y. Nonaka I. Acta Neuropathol. 1995; 89: 29-34Crossref PubMed Scopus (36) Google Scholar, 26Davis-Salinas J. Saporito-Irwin S.M. Cotman C.W. Van Nostrand W.E. J. Neurochem. 1995; 65: 931-934Crossref PubMed Scopus (159) Google Scholar), blood vessels (27Glenner G.C. Wong C.W. Biochem. Biophys. Res. Commun. 1984; 120: 885-890Crossref PubMed Scopus (4433) Google Scholar, 28Joachim C.L. Duffy L.K. Morris J.H. Selkoe D.J. Brain Res. 1988; 474: 100-111Crossref PubMed Scopus (161) Google Scholar), and in the kidneys, lungs, skin, subcutaneous tissue, and intestine of AD patients (29Skodras G. Peng J.H. Parker Jr., J.C. Kragel P.J. Ann. Clin. Lab. Sci. 1993; 23: 275-280PubMed Google Scholar, 30Joachim C.L. Mori H. Selkoe D.J. Nature. 1989; 341: 226-230Crossref PubMed Scopus (412) Google Scholar). Cerebral Aβ deposition occurs in other aged mammals that have the human Aβ sequence (31Vaughan D.W. Peters A. J. Neuropathol. Exp. Neurol. 1981; 40: 472-487Crossref PubMed Scopus (70) Google Scholar) but is not a feature of aged rats (32Johnstone E.M. Chaney M.O. Norris F.H. Pascual R. Little S.P. Mol. Brain Res. 1991; 10: 229Crossref Scopus (307) Google Scholar, 33Shivers B.D. Hilbich C. Multhaup G. Salbaum M. Beyreuther K. Seeburg P.H. EMBO J. 1988; 7: 1365-1370Crossref PubMed Scopus (410) Google Scholar). Although soluble Aβ1–40 is produced by rat neuronal tissue (34Busciglio J. Gabuzda D.H. Matsudaira P. Yanker B.A. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2092-2096Crossref PubMed Scopus (550) Google Scholar), it contains three amino acid substitutions (Arg → Gly, Tyr → Phe, and His → Arg at positions 5, 10, and 13, respectively (32Johnstone E.M. Chaney M.O. Norris F.H. Pascual R. Little S.P. Mol. Brain Res. 1991; 10: 229Crossref Scopus (307) Google Scholar)) that appear to alter the physicochemical properties of the peptide preventing it from precipitating in the neocortex. Aβ accumulates in the brain in AD and DS in forms that can be resolubilized in water (35Kuo Y.-M. Emmerling M.R. Vigo-Pelfrey C. Kasunic T.C. Kirkpatrick J.B. Murdoch G.H. Ball M.J. Roher A.E. J. Biol. Chem. 1996; 271: 4077-4081Abstract Full Text Full Text PDF PubMed Scopus (559) Google Scholar, 36Roher A.E. Chaney M.O. Kuo Y.-M. Webster S.D. Stine W.B. Haverkamp L.J. Woods A.S. Cotter R.J. Tuohy J.M. Krafft G.A. Bonnell B.S. Emmerling M.R. J. Biol. Chem. 1996; 271: 20631-20635Abstract Full Text Full Text PDF PubMed Scopus (466) Google Scholar) but also in forms that require harsher conditions to extract and exhibit associated SDS-resistant polymerization on polyacrylamide gel electrophoresis (35Kuo Y.-M. Emmerling M.R. Vigo-Pelfrey C. Kasunic T.C. Kirkpatrick J.B. Murdoch G.H. Ball M.J. Roher A.E. J. Biol. Chem. 1996; 271: 4077-4081Abstract Full Text Full Text PDF PubMed Scopus (559) Google Scholar, 37Masters C.L. Simms G. Weinman N.A. Multhaup G. McDonald B.L. Beyreuther K. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 4245-4249Crossref PubMed Scopus (3842) Google Scholar). Aβ1–40 is the predominant soluble species in biological fluids, whereas Aβ1–42, a minor species of Aβ that is more insoluble in vitro, is the predominant species found in plaques and deposits associated with AD and DS (35Kuo Y.-M. Emmerling M.R. Vigo-Pelfrey C. Kasunic T.C. Kirkpatrick J.B. Murdoch G.H. Ball M.J. Roher A.E. J. Biol. Chem. 1996; 271: 4077-4081Abstract Full Text Full Text PDF PubMed Scopus (559) Google Scholar, 36Roher A.E. Chaney M.O. Kuo Y.-M. Webster S.D. Stine W.B. Haverkamp L.J. Woods A.S. Cotter R.J. Tuohy J.M. Krafft G.A. Bonnell B.S. Emmerling M.R. J. Biol. Chem. 1996; 271: 20631-20635Abstract Full Text Full Text PDF PubMed Scopus (466) Google Scholar, 37Masters C.L. Simms G. Weinman N.A. Multhaup G. McDonald B.L. Beyreuther K. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 4245-4249Crossref PubMed Scopus (3842) Google Scholar, 38Murphy Jr., G.M. Forno L.S. Higgins L. Scardina J.M. Eng L.F. Cordell B. Am. J. Pathol. 1994; 144: 1082-1088PubMed Google Scholar, 39Mak K. Yang F. Vinters H.V. Frautschy S.A. Cole G.M. Brain Res. 1994; 667: 138-142Crossref PubMed Scopus (67) Google Scholar, 40Iwatsubo T. Mann D.M.A. Odaka A. Suzuki N. Ihara Y. Ann. Neurol. 1995; 37: 294-299Crossref PubMed Scopus (342) Google Scholar, 41Mann D.M.A. Iwatsubo T. Ihara Y. Cairns N.J. Lantos P.L. Bogdanovic N. Lannfelt L. Winblad B. Maat-Schieman M.L.C. Rossor M.N. Am. J. Pathol. 1996; 148: 1257-1266PubMed Google Scholar). We have pursued studies of the physicochemical properties of synthetic Aβ peptides in order to appraise the potential of various neurochemical environments to induce Aβ deposition. To this end, we had previously found that Aβ is strikingly precipitated by certain metals in vitro, in particular Zn2+ (42Bush A.I. Pettingell Jr., W.H. Paradis M.D. Tanzi R.E. J. Biol. Chem. 1994; 269: 12152-12158Abstract Full Text PDF PubMed Google Scholar, 43Bush A.I. Pettingell Jr., W.H. Multhaup G. Paradis M.D. Vonsattel J.-P. Gusella J.F. Beyreuther K. Masters C.L. Tanzi R.E. Science. 1994; 265: 1464-1467Crossref PubMed Scopus (1441) Google Scholar, 44Bush A.I. Moir R.D. Rosenkranz K.M. Tanzi R.E. Science. 1995; 268: 1921-1922Crossref PubMed Scopus (32) Google Scholar, 45Huang X. Atwood C.S. Moir R.D. Hartshorn M.A. Vonsattel J.-P. Tanzi T.E. Bush A.I. J. Biol. Chem. 1997; 272: 26464-26470Abstract Full Text Full Text PDF PubMed Scopus (313) Google Scholar). This is important since zinc and other biometals are concentrated in the brain neocortical parenchyma. A recent study, using micro particle-induced x-ray emission analyses of the cortical and accessory basal nuclei of the amygdala, demonstrated that levels of Zn2+, Fe3+, and Cu2+ are significantly elevated within AD neuropil compared with control neuropil and that these metal ions are significantly further concentrated within the core and periphery of plaque deposits (46Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998)J. Neurol. Sci., in pressGoogle Scholar). We have also found that the extraction of Aβ deposits from brain tissue into aqueous buffers is increased in the presence of chelators of Zn2+ and Cu2+ (47Cherny R. Masters C.L. Beyreuther K. Tanzi R.E. Fairlie D. Bush A.I. Soc. Neurosci. Abstr. 1997; 23: 534Google Scholar), providing further evidence that these metal ions participate in the deposition of Aβ within amyloid plaques. In common with the appearance of amorphous and amyloid deposits is the observation that altered neuronal H+ homeostasis may accompany Alzheimer's disease and head injury. AD is complicated by cerebral acidosis (pH 6.6; see Ref. 48Yates C.M. Butterworth J. Tennant M.C. Gordon A. J. Neurochem. 1990; 55: 1624-1630Crossref PubMed Scopus (247) Google Scholar), which may be related to impaired glucose metabolism (49Messier C. Gagnon M. Behav. Brain Res. 1996; 75: 1-11Crossref PubMed Scopus (206) Google Scholar) or to the inflammatory response seen in AD-affected brain tissue (reviewed in Refs. 50Griffin W.S.T. Sheng J.G. Mrak R.E. Wasco W. Tanzi R.E. Molecular Mechanisms of Dementia. Humana Press Inc., Totowa, NJ1997: 169-176Crossref Google Scholar and 51Rogers J. O'Barr S. Wasco W. Tanzi R.E. Molecular Mechanisms of Dementia. Humana Press Inc., Totowa, NJ1997: 177-198Crossref Google Scholar). The release of metal ions such as Cu+ and Fe2+ from metalloproteins is induced by a mildly acidotic environment (52Owen Jr., C.A. Proc. Soc. Exp. Biol. Med. 1975; 149: 681-682Crossref PubMed Scopus (13) Google Scholar, 53Princiotto J.V. Zapolski E.J. Biochim. Biophys. Acta. 1976; 428: 766-771Crossref PubMed Scopus (22) Google Scholar, 54Lestas A.N. Br. J. Haematol. 1976; 32: 341-350Crossref PubMed Scopus (100) Google Scholar, 55Baldwin D.A. De Sousa D.M.R. Von Wandruszka R.M.A. Biochim. Biophys. Acta. 1982; 719: 140-146Crossref PubMed Scopus (53) Google Scholar, 56Wardeska J.G. Viglione B.J. Chasteen N.D. Spik G. Montreuil J. Crichton R.R. Mazurier J. Proteins of Iron Storage and Transport. Elsevier Science Publishers B, 1985: 85-88Google Scholar, 57Brieland J.K. Fantone J.C. Arch. Biochem. Biophys. 1991; 284: 78-83Crossref PubMed Scopus (51) Google Scholar, 58Lamb D.J. Leake D.S. FEBS Lett. 1994; 338: 122-126Crossref PubMed Scopus (88) Google Scholar). Therefore, we investigated the effect of several bioessential metal ions on their ability to bind and alter the solubility of Aβ1–40/42 under mildly acidic conditions (pH ≥ 6.6) to determine whether there are any unforeseen interactions that may help explain the propensity for Aβ to precipitate under the mildly acidotic conditions anticipated within the metabolically diseased brain parenchyma. A striking and unexpected interaction between pH and Cu2+ was observed for human Aβ. Human Aβ1–40peptide was synthesized, purified, and characterized by high pressure liquid chromatography analysis (HPLC), amino acid analysis, and mass spectroscopy by the W. M. Keck Foundation Biotechnology Resource Laboratory (Yale University, New Haven, CT). Rat Aβ1–40was obtained from Quality Control Biochemicals, Inc. (Hopkington, MA). The HPLC elution profiles of both peptides in these working batches were identified as a single peak. Amino acid analysis of the synthetic peptides indicated no apparent chemical modifications in the amino acid residues. Synthetic Aβ peptide solutions were dissolved in trifluoroethanol (30% in Milli-Q water (Millipore Corp., Milford, MA)) or 20 mm Hepes (pH 8.5) at a concentration of 0.5–1.0 mg/ml, centrifuged for 20 min at 10,000 × g, and the supernatants (stock Aβ) used for subsequent aggregation assays on the day of the experiment. Prior to use all buffers and stock solutions of metal ions were filtered though a 0.22-μm filter (Gelman Sciences, Ann Arbor, MI) to remove any particulate matter. All metal ions were the chloride salt, except lead nitrate. The concentration of stock Aβ peptides, bovine serum albumin (BSA; Pierce), aprotinin (Sigma), and insulin (Sigma) was determined by spectrophotometric absorbance at 214 nm (against calibrated standard curves) or by Micro BCA protein assay (Pierce). The Micro BCA assay was performed by diluting 10 μl of stock Aβ (or BSA standard) in distilled, deionized water (140 μl) and then adding BCA reagent (150 μl) to a 96-well plate and measuring the absorbance at 562 nm. The validity of this assay was previously confirmed by amino acid analysis. To determine the centrifugation time required to completely sediment aggregated proteins, Aβ1–40 (2.5 μm) in 150 mm NaCl and 20 mm Hepes (pH 7.4) was incubated for 30 min at 37 °C with no metal, and under aggregating conditions of Zn2+ (100 μm), Cu2+ (100 μm), or pH 5.5. Reaction mixtures were centrifuged at 10,000 × g for different times or ultracentrifuged at 100,000 × g for 1 h. Centrifugation for >10 min at 10,000 × g was sufficient to completely sediment Zn2+-, Cu2+-, and pH-induced aggregates of Aβ1–40 when compared with ultracentrifugation (100,000 × g for 1 h). Therefore, centrifugation for 10–20 min at 10,000 × g was used in subsequent assays to sediment aggregated particles. To quantitate the effects of different metals and pH on protein solubility, synthetic Aβ stock, and BSA, aprotinin and insulin stocks were diluted to 2.5 μm in 150 mm NaCl in either 20 mm glycine (pH 3.0–4.5), MES (pH 5.0–6.2), or Hepes (pH 6.4–8.8) and then incubated (37 °C) with or without metal ions for 30 min. The resultant aggregated particles were sedimented by centrifugation (20 min, 10,000 × g), and soluble protein was measured in the supernatant by the Micro BCA protein assay. Cu2+ concentrations were determined using the spectrophotometric method of Matsuba and Takahashi (59Matsuba Y. Takahashi Y. Anal. Biochem. 1970; 36: 182-191Crossref PubMed Scopus (27) Google Scholar), adapted to microtiter plate volumes. Sample Cu2+ concentrations were determined from a Cu2+ standard curve (0–100 μm in 20 mm ammonium acetate, 150 mm NaCl (pH 7.4)). Cu2+-induced spectral changes in Aβ were monitored by incubating Aβ1–40 or Aβ1–42 (5 μm) in 20 mm ammonium acetate buffer, 150 mm NaCl (pH 7.4), with and without various concentrations of Cu2+ for 5 min prior to loading onto a quartz microtiter plate. Absorbance was scanned between 200 and 800 nm on a Spectramax Plus Spectrophotometer (Molecular Devices, Sunnyvale, CA). Incubation of Cu2+ with Aβ induced a change in the absorbance profile of the peptide which was maximal at 208 nm. However, subsequent analyses were performed at 214 nm where the spectral shift was still large but the background signal was lower. By using Aβ aggregation as an end point for Cu2+ binding, the stoichiometry of Cu2+ binding to Aβ1–40was determined by incubating Aβ1–40 (10 μm) in 20 mm ammonium acetate, 150 mm NaCl (pH 7.4) for 30 min at 37 °C with Cu2+ or Cu2+-(glycine)2 (50 μm) (60Masuoka J. Hegenauer J. Van Dyke B.R. Saltman P. J. Biol. Chem. 1993; 268: 21533-21537Abstract Full Text PDF PubMed Google Scholar). Reaction mixtures were centrifuged at 10,000 × g for 20 min, and the ratio of Cu2+ binding to Aβ was estimated by determining the concentrations of soluble Aβ and Cu2+ remaining in the supernatant. It was determined that the presence of Aβ did not affect the assay. Turbidity measurements, as an assay for aggregation, were performed in a flat-bottomed 96-well microtiter plate (Corning Costar Corp.), and absorbances (405 nm) were measured using a Spectramax Plus spectrophotometric microplate reader (Molecular Devices, Sunnyvale, CA). Automatic 30-s plate agitation mode was selected for the plate reader to evenly suspend the aggregates in the wells before all readings. Aβ1–40 stock was brought to 10 μm (300 μl) in 20 mm Hepes buffer, 150 mm NaCl (pH 6.6, 6.8 or 7.4) ± metal ions prior to incubation (30 min, 37 °C) and absorbance measurement. To investigate the reversibility of Cu2+-induced Aβ aggregation, 25 μm Aβ1–40 and 25 μm Cu2+ were mixed in 67 mmphosphate buffer containing 150 mm NaCl (pH 7.4), to a final volume of 200 μl. Turbidity measurements were taken at four 1-min intervals. Subsequently, 20-μl aliquots of 10 mmEDTA or 10 mm Cu2+ were added to the wells alternatively, and following a 2-min delay, a further four readings were taken at 1-min intervals. After the final EDTA addition and turbidity reading, the mixtures were incubated for an additional 30 min before taking final readings. To investigate the reversibility of pH-mediated Cu2+-induced Aβ1–40 aggregation, 10 μm Aβ1–40 and 30 μmCu2+ were mixed in 67 mm phosphate buffer containing 150 mm NaCl (pH 7.4), and an initial turbidity measurement was taken. Subsequently, the pH of the solution was successively decreased to 6.6 with 0.1 m HCl and then increased back to 7.4 with 0.1 m NaOH. The pH of the reaction was monitored with a microprobe (Lazar Research Laboratories Inc., Los Angeles, CA) and the turbidity read at 5-min intervals for up to 30 min. This cycle was repeated three times. Blockage of histidine residues was achieved by incubating Aβ1–40 (1.5 mg/ml dissolved in distilled, deionized H2O, following centrifugation (10,000 × g for 20 min) to remove undissolved peptide) with 5 mm diethyl pyrocarbonate (DEPC) in 25 mm phosphate buffer (pH 7.4) for 30 min at 4 °C (61Badet-Denisot M.-A. Badet B. Arch. Biochem. Biophys. 1992; 292: 475-478Crossref PubMed Scopus (20) Google Scholar). Formation of N-carbethoxyhistidine residues was followed by the characteristic increase in absorbance at 240 nm (62Lundblad R.L. Noyes C.M. Chemical Reagents for Protein Modification. 1. CRC Press, Inc., Boca Raton, FL1988: 105-126Google Scholar). The modified protein was dialyzed extensively to remove excess DEPC, and its ability to aggregate at pH 7.4 and 6.6 with and without Cu2+, Fe3+, and Zn2+ was tested as described above. Subsequently, reversal of the histidine modification was achieved by incubating the modified protein with 0.1 mhydroxylamine hydrochloride in 25 mm phosphate buffer (pH 7.4) for 30 min at 4 °C. The restored peptide was dialyzed extensively to remove excess hydroxylamine hydrochloride, and its ability to aggregate at pH 7.4 and 6.6 with and without Cu2+, Fe3+ and Zn2+ was retested. Stock Aβ1–40 or Aβ1–42 (1 mg/ml) was diluted to a final concentration of 200 ng in 1 ml (44 nm) of buffer containing 150 mm NaCl, 20 mm Tris (pH 7.4 or 6.6), 0.1 μm BSA and CuCl2 (0, 0.1, 0.5, 1 or 5 μm), and the samples were mixed and then incubated (30 min, 37 °C). The reaction mixtures were then centrifuged at 12,000 × g for 10 min in a fixed angle rotor centrifuge, and the supernatant was carefully removed leaving a pellet of aggregated Aβ on the side of the tube. Sample buffer (30 μl; containing 4% SDS, 5% β-mercaptoethanol) was added to the tubes which were vigorously mixed, then heated to 95 °C for 5 min, and spun briefly. The SDS-extracted samples and a standard containing 50 ng of Aβ in sample buffer were loaded and analyzed by polyacrylamide gel electrophoresis (Tricine gels, 10–20%; Novex, San Diego, CA), transferred to polyvinylidene difluoride membranes (Bio-Rad), fixed, blocked, and then probed with the anti-Aβ monoclonal antibody 6E10 (Senetek, Maryland Heights, MI) overnight at 4 °C. The blot was then incubated with anti-mouse horseradish peroxidase conjugate (Pierce) for 2 h at 22 °C and incubated (5 min) with Supersignal Ultra (Pierce) according to the manufacturer's instructions. The chemiluminescent signal was captured for 10 min at maximum sensitivity using the Fluoro-S Image Analysis System (Bio-Rad), and the electronic images were analyzed using Multi-Analyst Software (Bio-Rad). This chemiluminescent image analysis system is linear over 2 orders of magnitude and has comparable sensitivity to film. Aβ1–40 or Aβ1–42 (~1 mg/ml) stock solutions were diluted to 20 nm in buffer containing 150 mm NaCl, 20 mm Tris (pH 7.4 or 6.6), 0.1 μm BSA and CuCl2 (0, 0.1, 0.2, 0.3, 0.5, 1, or 2 μm) added, and the samples were incubated (15 min, 37 °C). The reaction mixtures (200 μl) were then placed into the 96-well Easy-Titer ELIFA system (Pierce) and filtered through a 0.22-μm cellulose acetate filter (MSI, Westboro, MA). Aggregated particles were fixed to the membrane (0.1% glutaraldehyde, 15 min), washed thoroughly with Tris-buffered saline, and then probed with the anti-Aβ monoclonal antibody 6E10 (Senetek, Maryland Heights, MI) overnight at 4 °C. Blots were then processed as described above. To determine the effect of mild acidity on the behavior of Aβ in the presence of different metals, Aβ1–40 was incubated with different bioessential metal ions at pH 6.6, 6.8, and 7.4 at total metal ion concentrations observed in serum (Fig.1, A and B). Peptide aggregation was measured by sedimentation (Fig. 1 A) and turbidometry (Fig. 1 B), which generally gave confirmatory results. Incubation of Aβ in the absence of metal ions induced no detectable aggregation over the pH range tested. Only incubation with Zn2+ or Cu2+ induced >30% aggregation under these conditions (Fig. 1 A). As the [H+] was increased, all other metal ions induced an observable increase in sedimented Aβ (Fig. 1 A), but Cu2+ induced the most striking increase in Aβ aggregation as measured by both sedimentation and turbidometry. Fe3+induced a marked increase in turbidity (Fig. 1 B), but this aggregate was not as readily sedimented as the Cu2+- or Zn2+-induced Aβ aggregates (Fig. 1 A), probably due to decreased density of the assembly. As expected, Zn2+induced ~50% of the soluble peptide to sediment over the pH range tested, but increasing the [H+] caused a decrease in Zn2+-induced turbidity (Fig. 1 B) which may be due to an alteration in the size or light scattering properties of the Zn2+-induced aggregates. Incubation of the mixtures for 16 h did not induce any appreciable change in the turbidometry readings compared with the original readings (data not shown), suggesting that the aggregation reactions had reached equilibrium within 30 min. The effects of higher metal ion concentrations were also compared at equimolar (30 μm) concentrations (Fig. 1 C). Under these conditions, as the [H+] increased, Ni2+ induced Aβ aggregation (~85%) which was comparable to the effect of incubation with the same concentration of Cu2+. Co2+ induced a comparable level of Aβ aggregation to Zn2+ (~70%) and, like Zn2+, Co2+-induced aggregation was independent of [H+]. At 30 μm, Fe3+, Al3+, and Pb2+ were observed to induce partial (~30%) Aβ aggregation at pH 6.6 but no significant aggregation at pH 7.4. To quantify the binding affinity of Cu2+ for Aβ, spectral analysis was performed. The half-maximal binding of Cu2+for Aβ1–40 and Aβ1–42 based upon shift in absorbance was estimated as 4.0 and 0.3 μm, respectively (Fig. 2, A and B). The stoichiometry of Cu2+ binding to Aβ1–40in the Cu2+-induced Aβ aggregate was 3.4 and 3.0 at pH 7.0 and 6.6, respectively. The stoichiometry of Cu2+binding to Aβ1–40 required for precipitation is in agreement with that required for the saturation of the spectral shift (Fig. 2 A). Cu2+ supplied as a Cu2+-(glycine)2 complex did not alter the amount of Aβ aggregation or binding stoichiometry compared with that induced by non-complexed Cu2+ in the same buffer (data not shown). Next, w
What problem does this paper attempt to address?
-
Characterization of Copper Interactions with Alzheimer Amyloid β Peptides
Craig S. Atwood,Richard C. Scarpa,Xudong Huang,Robert D. Moir,Walton D. Jones,David P. Fairlie,Rudolph E. Tanzi,Ashley I. Bush
DOI: https://doi.org/10.1046/j.1471-4159.2000.0751219.x
2000-01-01
Journal of Neurochemistry
Abstract:Abstract: Cu and Zn have been shown to accumulate in the brains of Alzheimer's disease patients. We have previously reported that Cu2+ and Zn2+ bind amyloid β (Aβ), explaining their enrichment in plaque pathology. Here we detail the stoichiometries and binding affinities of multiple cooperative Cu2+‐binding sites on synthetic Aβ1‐40 and Aβ1‐42. We have developed a ligand displacement technique (competitive metal capture analysis) that uses metal‐chelator complexes to evaluate metal ion binding to Aβ, a notoriously self‐aggregating peptide. This analysis indicated that there is a very‐high‐affinity Cu2+‐binding site on Aβ1‐42 (log Kapp = 17.2) that mediates peptide precipitation and that the tendency of this peptide to self‐aggregate in aqueous solutions is due to the presence of trace Cu2+ contamination (customarily ∼0.1 μM). In contrast, Aβ1‐40 has much lower affinity for Cu2+ at this site (estimated log Kapp = 10.3), explaining why this peptide is less self‐aggregating. The greater Cu2+‐binding affinity of Aβ1‐42 compared with Aβ1‐40 is associated with significantly diminished negative cooperativity. The role of trace metal contamination in inducing Aβ precipitation was confirmed by the demonstration that Aβ peptide (10 μM) remained soluble for 5 days only in the presence of high‐affinity Cu2+‐selective chelators.
-
Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar-Affinity Copper Binding Site on Amyloid β1-42
Craig S. Atwood,Richard C. Scarpa,Xudong Huang,Robert D. Moir,Walton D. Jones,David P. Fairlie,Rudolph E. Tanzi,Ashley I. Bush
DOI: https://doi.org/10.1046/j.1471-4159.2000.0751219.x
2008-01-01
Journal of Neurochemistry
Abstract:Cu and Zn have been shown to accumulate in the brains of Alzheimer's disease patients. We have previously reported that Cu2+ and Zn2+ bind amyloid beta (A beta), explaining their enrichment in plaque pathology. Here we detail the stoichiometries and binding affinities of multiple cooperative Cu2+-binding sites on synthetic A beta 1-40 and A beta 1-42. We have developed a ligand displacement technique (competitive metal capture analysis) that uses metal-chelator complexes to evaluate metal ion binding to A beta, a notoriously self-aggregating peptide. This analysis indicated that there is a very-high-affinity Cu2+-binding site on A beta 1-42 (log K-app = 17.2) that mediates peptide precipitation and that the tendency of this peptide to self-aggregate in aqueous solutions is due to the presence of trace Cu2+ contamination (customarily similar to 0.1 mu M). In contrast, A beta 1-40 has much lower affinity for Cu2+ at this site (estimated log K-app = 10.3), explaining why this peptide is less self-aggregating. The greater Cu2+-binding affinity of A beta 1-42 compared with A beta 1-40 is associated with significantly diminished negative cooperativity, The role of trace metal contamination in inducing A beta precipitation was confirmed by the demonstration that A beta peptide (10 mu M) remained soluble for 5 days only in the presence of high-affinity Cu2+-selective chelators.
-
Zinc-Induced Alzheimer'S A Beta 1-40 Aggregation Is Mediated By Conformational Factors
Xd Huang,Cs Atwood,Rd Moir,Ma Hartshorn,Jp Vonsattel,Re Tanzi,Ai Bush
DOI: https://doi.org/10.1074/jbc.272.42.26464
IF: 5.485
1997-01-01
Journal of Biological Chemistry
Abstract:The heterogeneous precipitates of A beta that accumulate in the brain cortex in Alzheimer's disease possess varying degrees of resistance to resolubilization. We previously found that A beta 1-40 is rapidly precipitated in vitro by physiological concentrations of zinc, a neurochemical that is highly abundant in brain compartments where A beta is most likely to precipitate. We now present evidence that the zinc-induced precipitation of A beta is mediated by a peptide dimer and favored by conditions that promote alpha-helical and diminish beta-sheet conformations. The manner in which the synthetic peptide is solubilized was critical to its behavior in vitro. Zinc-induced A beta aggregation was dependent upon the presence of NaCl, was enhanced when the peptide stock solution was stored frozen. The A beta aggregates induced by zinc were reversible by chelation, but could then be reprecipitated by zinc for several cycles, indicating that the peptide's conformation is probably preserved in the zinc-mediated assembly. In contrast, A beta aggregates induced by low pH (5.5) were not resolubilized by returning the pH milieu to 7.4. The zinc-A beta interaction exhibits features resembling the gelation process of zinc-mediated fibrin assembly, suggesting that, in events such as clot formation or injury, reversible A beta assembly could be physiologically purposive. Such a mechanism is contemplated in the early evolution of diffuse plaques in Alzheimer's disease and suggests a possible therapeutic strategy for the resolubilization of some forms of A beta deposit in the disease.
-
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Xudong Huang,Craig S Atwood,Robert D Moir,Mariana A Hartshorn,Rudolph E Tanzi,Ashley I Bush
DOI: https://doi.org/10.1007/s00775-004-0602-8
2004-01-01
Abstract:Nucleation-dependent protein aggregation ("seeding") and amyloid fibril-free formation of soluble SDS-resistant oligomers ("oligomerization") by hydrophobic interaction is an in vitro model thought to propagate beta-amyloid (Abeta) deposition, accumulation, and incur neurotoxicity and synaptotoxicity in Alzheimer's disease (AD), and other amyloid-associated neurodegenerative diseases. However, Abeta is a high-affinity metalloprotein that aggregates in the presence of biometals (zinc, copper, and iron), and neocortical Abeta deposition is abolished by genetic ablation of synaptic zinc in transgenic mice. We now present in vitro evidence that trace (<or=0.8 microM) levels of zinc, copper, and iron, present as common contaminants of laboratory buffers and culture media, are the actual initiators of the classic Abeta1-42-mediated seeding process and Abeta oligomerization. Replicating the experimental conditions of earlier workers, we found that the in vitro precipitation and amyloidosis of Abeta1-40 (20 microM) initiated by Abeta1-42 (2 microM) were abolished by chelation of trace metal contaminants. Further, metal chelation attenuated formation of soluble Abeta oligomers from a cell-free culture medium. These data suggest that protein self-assembly and oligomerization are not spontaneous in this system as previously thought, and that there may be an obligatory role for metal ions in initiating Abeta amyloidosis and oligomerization.
-
Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
Nima Sasanian,David Bernson,Istvan Horvath,Pernilla Wittung-Stafshede,Elin K Esbjörner,Elin K. Esbjörner
DOI: https://doi.org/10.3390/biom10060924
IF: 6.064
2020-06-18
Biomolecules
Abstract:Plaque deposits composed of amyloid-β (Aβ) fibrils are pathological hallmarks of Alzheimer’s disease (AD). Although copper ion dyshomeostasis is apparent in AD brains and copper ions are found co-deposited with Aβ peptides in patients’ plaques, the molecular effects of copper ion interactions and redox-state dependence on Aβ aggregation remain elusive. By combining biophysical and theoretical approaches, we here show that Cu2+ (oxidized) and Cu+ (reduced) ions have opposite effects on the assembly kinetics of recombinant Aβ(1-42) into amyloid fibrils in vitro. Cu2+ inhibits both the unseeded and seeded aggregation of Aβ(1-42) at pH 8.0. Using mathematical models to fit the kinetic data, we find that Cu2+ prevents fibril elongation. The Cu2+-mediated inhibition of Aβ aggregation shows the largest effect around pH 6.0 but is lost at pH 5.0, which corresponds to the pH in lysosomes. In contrast to Cu2+, Cu+ ion binding mildly catalyzes the Aβ(1-42) aggregation via a mechanism that accelerates primary nucleation, possibly via the formation of Cu+-bridged Aβ(1-42) dimers. Taken together, our study emphasizes redox-dependent copper ion effects on Aβ(1-42) aggregation and thereby provides further knowledge of putative copper-dependent mechanisms resulting in AD.
biochemistry & molecular biology
-
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides
Xudong Huang,Craig S. Atwood,Robert D. Moir,Mariana A. Hartshorn,Rudolph E. Tanzi,Ashley I. Bush
DOI: https://doi.org/10.1007/s00775-004-0602-8
2004-01-01
JBIC Journal of Biological Inorganic Chemistry
Abstract:Nucleation-dependent protein aggregation (“seeding”) and amyloid fibril-free formation of soluble SDS-resistant oligomers (“oligomerization”) by hydrophobic interaction is an in vitro model thought to propagate β-amyloid (Aβ) deposition, accumulation, and incur neurotoxicity and synaptotoxicity in Alzheimer’s disease (AD), and other amyloid-associated neurodegenerative diseases. However, Aβ is a high-affinity metalloprotein that aggregates in the presence of biometals (zinc, copper, and iron), and neocortical Aβ deposition is abolished by genetic ablation of synaptic zinc in transgenic mice. We now present in vitro evidence that trace (≤0.8 µM) levels of zinc, copper, and iron, present as common contaminants of laboratory buffers and culture media, are the actual initiators of the classic Aβ1–42-mediated seeding process and Aβ oligomerization. Replicating the experimental conditions of earlier workers, we found that the in vitro precipitation and amyloidosis of Aβ1–40 (20 µM) initiated by Aβ1–42 (2 µM) were abolished by chelation of trace metal contaminants. Further, metal chelation attenuated formation of soluble Aβ oligomers from a cell-free culture medium. These data suggest that protein self-assembly and oligomerization are not spontaneous in this system as previously thought, and that there may be an obligatory role for metal ions in initiating Aβ amyloidosis and oligomerization.
-
Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers
Michael R Nichols,Melissa A Moss,Dana Kim Reed,Jan H Hoh,Terrone L Rosenberry
DOI: https://doi.org/10.1002/jemt.20189
Abstract:The deposition of aggregated amyloid-beta (Abeta) peptides in the brain as senile plaques is a pathological hallmark of Alzheimer's disease (AD). Several lines of evidence indicate that fibrillar and, in particular, soluble aggregates of these 40- and 42-residue peptides are important in the etiology of AD. Recent studies also stress that amyloid aggregates are polymorphic and that a single polypeptide can fold into multiple amyloid conformations. Here we review our recent reports that Abeta(1-40) in vitro can form soluble aggregates with predominant beta-structures that differ in stability and morphology. One class of aggregates involved soluble Abeta protofibrils, prepared by vigorous overnight agitation of monomeric Abeta(1-40) in low ionic strength buffers. These aggregates were quite stable and disaggregated to only a limited extent on dilution. A second class of soluble Abeta aggregates was generated at polar-nonpolar interfaces. Aggregation in a two-phase system of buffer over chloroform occurred more rapidly than in buffer alone. In buffered 2% hexafluoroisopropanol (HFIP), microdroplets of HFIP were formed and the half-time for aggregation was less than 10 minutes. Like Abeta protofibrils, these interfacial aggregates showed increased thioflavin T fluorescence and were rich in beta-structure by circular dichroism. However, electron microscopy and atomic force microscopy revealed very different morphologies. The HFIP aggregates formed initial globular clusters that progressed over several days to soluble fibrous aggregates. When diluted out of HFIP these aggregates initially were very unstable and disaggregated completely within 2 minutes. However, their stability increased as they progressed to fibers. It is important to determine whether similar interfacial Abeta aggregates are produced in vivo.
-
Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)
Xiao Dong,Wei Chen,Normand Mousseau,Philippe Derreumaux
DOI: https://doi.org/10.1063/1.2890033
IF: 4.304
2008-01-01
The Journal of Chemical Physics
Abstract:The cytoxicity of Alzheimer’s disease has been linked to the self-assembly of the 40∕42 amino acid of the amyloid-β (Aβ) peptide into oligomers. To understand the assembly process, it is important to characterize the very first steps of aggregation at an atomic level of detail. Here, we focus on the N-terminal fragment 1–28, known to form fibrils in vitro. Circular dichroism and NMR experiments indicate that the monomer of Aβ(1–28) is α-helical in a membranelike environment and random coil in aqueous solution. Using the activation-relaxation technique coupled with the OPEP coarse grained force field, we determine the structures of the monomer and of the dimer of Aβ(1–28). In agreement with experiments, we find that the monomer is predominantly random coil in character, but displays a non-negligible β-strand probability in the N-terminal region. Dimerization impacts the structure of each chain and leads to an ensemble of intertwined conformations with little β-strand content in the region Leu17-Ala21. All these structural characteristics are inconsistent with the amyloid fibril structure and indicate that the dimer has to undergo significant rearrangement en route to fibril formation.
-
Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation
Krushna Sonar,Ricardo L Mancera
DOI: https://doi.org/10.1021/acs.jpcb.2c04743
2022-10-13
Abstract:Intrinsically disordered peptides, such as amyloid β42 (Aβ42), lack a well-defined structure in solution. Aβ42 can undergo abnormal aggregation and amyloidogenesis in the brain, forming fibrillar plaques, a hallmark of Alzheimer's disease. The insoluble fibrillar forms of Aβ42 exhibit well-defined, cross β-sheet structures at the molecular level and are less toxic than the soluble, intermediate disordered oligomeric forms. However, the mechanism of initial interaction of monomers and subsequent oligomerization is not well understood. The structural disorder of Aβ42 adds to the challenges of determining the structural properties of its monomers, making it difficult to understand the underlying molecular mechanism of pathogenic aggregation. Certain regions of Aβ42 are known to exhibit helical propensity in different physiological conditions. NMR spectroscopy has shown that the Aβ42 monomer at lower pH can adopt an α-helical conformation and as the pH is increased, the peptide switches to β-sheet conformation and aggregation occurs. CD spectroscopy studies of aggregation have shown the presence of an initial spike in the amount of α-helical content at the start of aggregation. Such an increase in α-helical content suggests a mechanism wherein the peptide can expose critical non-polar residues for interaction, leading to hydrophobic aggregation with other interacting peptides. We have used molecular dynamics simulations to characterize in detail the conformational landscape of monomeric Aβ42 in solution to identify molecular properties that may mediate the early stages of oligomerization. We hypothesized that conformations with α-helical structure have a higher probability of initiating aggregation because they increase the hydrophobicity of the peptide. Although random coil conformations were found to be the most dominant, as expected, α-helical conformations are thermodynamically accessible, more so than β-sheet conformations. Importantly, for the first time α-helical conformations are observed to increase the exposure of aromatic and hydrophobic residues to the aqueous solvent, favoring their hydrophobically driven interaction with other monomers to initiate aggregation. These findings constitute a first step toward characterizing the mechanism of formation of disordered, low-order oligomers of Aβ42.
-
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
Craig S. Atwood,George Perry,Hong Zeng,Yoji Kato,Walton D. Jones,Ke-Qing Ling,Xudong Huang,Robert D. Moir,Dandan Wang,Lawrence M. Sayre,Mark A. Smith,Shu G. Chen,Ashley I. Bush
DOI: https://doi.org/10.1021/bi0358824
IF: 3.321
2004-01-01
Biochemistry
Abstract:We have previously reported that amyloid Abeta, the major component of senile plaques in Alzheimer's disease (AD), binds Cu with high affinity via histidine and tyrosine residues [Atwood, C. S., et al. (1998) J. Biol. Chem. 273, 12817-12826; Atwood, C. S., et al. (2000) J. Neurochem. 75, 12191233] and produces H2O2 by catalyzing the reduction of Cu(II) or Fe(III) [Huang, X., et al. (1999) Biochemistry 38, 7609-7616; Huang, X., et al. (1999) J. Biol. Chem. 274, 37111-37116]. Incubation with Cu induces the SDS-resistant oligomerization of Abeta [Atwood, C. S., et al. (2000) J. Neurochem. 75, 1219-1233], a feature characteristic of neurotoxic soluble Abeta extracted from the AD brain. Since residues coordinating Cu are most vulnerable to oxidation, we investigated whether modifications of these residues were responsible for Abeta cross-linking. SDS-resistant oligomerization of Abeta caused by incubation with Cu was found to induce a fluorescence signal characteristic of tyrosine cross-linking. Using ESI-MS and a dityrosine specific antibody, we confirmed that Cu(II) (at concentrations lower than that associated with amyloid plaques) induces the generation of dityrosine-cross-linked, SDS-resistant oligomers of human, but not rat, Abeta peptides. The addition of H2O2 strongly promoted Cu-induced dityrosine cross-linking of Abeta1-28, Abeta1-40, and Abeta1-42, suggesting that the oxidative coupling is initiated by interaction of H2O2 with a Cu(II) tyrosinate. The dityrosine modification is significant since it is highly resistant to proteolysis and is known to play a role in increasing structural strength. Given the elevated concentration of Cu in senile plaques, our results suggest that Cu interactions with Abeta could be responsible for causing the covalent cross-linking of Abeta in these structures.
-
Alzheimer's disease, beta-amyloid protein and zinc.
X Huang,M P Cuajungco,C S Atwood,R D Moir,R E Tanzi,A I Bush
DOI: https://doi.org/10.1093/jn/130.5.1488s
IF: 4.735
2000-01-01
Journal of Nutrition
Abstract:Alzheimer's disease (AD) is characterized by amyloid deposits within the neocortical parenchyma and the cerebrovasculature. The main component of these predominantly extracellular collections, A beta, which is normally a soluble component of all biological fluids, is cleaved out of a ubiquitously expressed parent protein, the amyloid protein precursor (APP), one of the type 1 integral membrane glycoproteins, Considerable evidence has indicated that there is zinc dyshomeostasis and abnormal cellular zinc mobilization in AD. We have characterized both APP and A beta as copper/zinc metalloproteins, Zinc, copper and iron have recently been reported to be concentrated to 0.5 to 1 mmol/L in amyloid plaque. In vitro, rapid A beta aggregation is mediated by Zn(ll), promoted by the alpha-helical structure of A beta, and is reversible with chelation, In addition, A beta produces hydrogen peroxide in a Cu(ll)/Fe(lll)-dependent manner, and the hydrogen peroxide formation is quenched by Zn(ll), Moreover, zinc preserves the nontoxic properties of A beta, Although the zinc-binding proteins apolipoprotein E epsilon 4 allele and alpha(2)-macroglobulin have been characterized as two genetic risk factors for AD, zinc exposure as a risk factor for AD has not been rigorously studied. Based on our findings, we envisage that zinc may serve twin roles by both initiating amyloid deposition and then being involved in mechanisms attempting to quench oxidative stress and neurotoxicity derived from the amyloid mass. Hence, it remains debatable whether zinc supplementation is beneficial or deleterious for AD until additional studies clarify the issue.
-
Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations
R D Moir,C S Atwood,D M Romano,M H Laurans,X Huang,A I Bush,J D Smith,R E Tanzi
DOI: https://doi.org/10.1021/bi982437d
IF: 3.321
1999-04-06
Biochemistry
Abstract:The epsilon 4 allele of apolipoprotein E (APOE) has been found to be a risk factor for late-onset Alzheimer's disease (AD). While the pathogenic mechanism of APOE in AD is not yet clear, APOE isoforms appear to differentially influence the aggregation of A beta, the principal component of Alzheimer-associated beta-amyloid deposits. To date, no data are available for the propensity of A beta to aggregate in the presence of APOE under conditions where these components are at physiological concentrations (in cerebrospinal fluid, APOE and A beta are approximately 100 nM and approximately 5 nM, respectively). We employed a novel in vitro filtration assay for detecting zinc(II)- and copper(II)-induced aggregation of A beta in solutions containing concentrations of the peptide that are similar to those reported for human cerebrospinal fluid. The potential for resolubilization with EDTA and the relative densities of zinc- and copper-induced A beta aggregates were also compared. Zinc-induced A beta aggregates were found to be denser and less easily resolubilized than copper-induced precipitates. Metal-induced aggregation of A beta was studied in the presence of purified apolipoprotein E2, apolipoprotein E3, and apolipoprotein E4 under conditions that approximate the physiological concentrations and ratios of these proteins. In the presence of all three APOE isoforms, zinc-induced aggregation of A beta was attenuated, while precipitation with copper was enhanced. Consistent with the increased risk for AD associated with the epsilon 4 allele of APOE, metal-induced aggregation of A beta was highest for both zinc and copper in the presence of apolipoprotein E4. Our data are consistent with a role for APOE as an in vivo molecular chaperone for A beta.
-
Exploration of the Potential Role for Aβ in Delivery of Extracellular Copper to Ctr1
Ewelina Stefaniak,M Jake Pushie,Catherine Vaerewyck,David Corcelli,Chloe Griggs,Whitney Lewis,Emma Kelley,Noreen Maloney,Madison Sendzik,Wojciech Bal,Kathryn L Haas
DOI: https://doi.org/10.1021/acs.inorgchem.0c02100
2020-12-07
Abstract:Amyloid beta (Aβ) peptides are notorious for their involvement in Alzheimer's disease (AD), by virtue of their propensity to aggregate to form oligomers, fibrils, and eventually plaques in the brain. Nevertheless, they appear to be essential for correct neurophysiology on the synaptic level and may have additional functions including antimicrobial activity, sealing the blood-brain barrier, promotion of recovery from brain injury, and even tumor suppression. Aβ peptides are also avid copper chelators, and coincidentally copper is significantly dysregulated in the AD brain. Copper (Cu) is released in significant amounts during calcium signaling at the synaptic membrane. Aβ peptides may have a role in maintaining synaptic Cu homeostasis, including as a scavenger for redox-active Cu and as a chaperone for clearing Cu from the synaptic cleft. Here, we employed the Aβ1-16 and Aβ4-16 peptides as well-established non-aggregating models of major Aβ species in healthy and AD brains, and the Ctr1-14 peptide as a model for the extracellular domain of the human cellular copper transporter protein (Ctr1). With these model peptides and a number of spectroscopic techniques, we investigated whether the Cu complexes of Aβ peptides could provide Ctr1 with either Cu(II) or Cu(I). We found that Aβ1-16 fully and rapidly delivered Cu(II) to Ctr1-14 along the affinity gradient. Such delivery was only partial for the Aβ4-16/Ctr1-14 pair, in agreement with the higher complex stability for the former peptide. Moreover, the reaction was very slow and took ca. 40 h to reach equilibrium under the given experimental conditions. In either case of Cu(II) exchange, no intermediate (ternary) species were present in detectable amounts. In contrast, both Aβ species released Cu(I) to Ctr1-14 rapidly and in a quantitative fashion, but ternary intermediate species were detected in the analysis of XAS data. The results presented here are the first direct evidence of a Cu(I) and Cu(II) transfer between the human Ctr1 and Aβ model peptides. These results are discussed in terms of the fundamental difference between the peptides' Cu(II) complexes (pleiotropic ensemble of open structures of Aβ1-16 vs the rigid closed-ring system of amino-terminal Cu/Ni binding Aβ4-16) and the similarity of their Cu(I) complexes (both anchored at the tandem His13/His14, bis-His motif). These results indicate that Cu(I) may be more feasible than Cu(II) as the cargo for copper clearance from the synaptic cleft by Aβ peptides and its delivery to Ctr1. The arguments in favor of Cu(I) include the fact that cellular Cu export and uptake proteins (ATPase7A/B and Ctr1, respectively) specifically transport Cu(I), the abundance of extracellular ascorbate reducing agent in the brain, and evidence of a potential associative (hand-off) mechanism of Cu(I) transfer that may mirror the mechanisms of intracellular Cu chaperone proteins.
-
Investigating Cu(I) binding to model peptides of N-terminal Aβ isoforms
Abigail Strausbaugh Hjelmstad,M. Jake Pushie,Kaylee Ruth,Maria Escobedo,Kristin Kuter,Kathryn Haas
DOI: https://doi.org/10.1016/j.jinorgbio.2024.112480
IF: 4.336
2024-01-10
Journal of Inorganic Biochemistry
Abstract:Amyloid beta (Aβ) peptides and copper (Cu) ions are each involved in critical biological processes including antimicrobial activity, regulation of synaptic function, angiogenesis, and others. Aβ binds to Cu and may play a role in Cu trafficking. Aβ peptides exist in isoforms that vary at their C-and N-termini; variation at the N-terminal sequence affects Cu binding affinity, structure, and redox activity by providing different sets of coordinating groups to the metal ion. Several N-terminal isoforms have been detected in human brain tissues including Aβ 1–40/42 , Aβ 3–42 , pEAβ 3–42 , Aβ 4–42 , Aβ 11–40 and pEAβ 11–40 (where pE denotes an N-terminal pyroglutamic acid). Several previous works have individually investigated the affinity and structure of Cu(I) bound to some of these isoforms' metal binding domains. However, the disparately reported values are apparent constants collected under different sets of conditions, and thus an integrated comparison cannot be made. The work presented here provides the Cu(I) coordination structure and binding affinities of these six biologically relevant Aβ isoforms determined in parallel using model peptides of the Aβ metal binding domains (Aβ 1–16 , Aβ 3–16 , pEAβ 3–16 , Aβ 4–16 , Aβ 11–16 and pEAβ 11–16 ). The binding affinities of Cu(I)-Aβ complexes were measured using solution competition with ferrozine (Fz) and bicinchoninic acid (BCA) –two colorimetric Cu(I) indicators in common use. The Cu(I) coordination structures were characterized by X-ray absorption spectroscopy. The data presented here facilitates comparison of the isoforms' Cu-binding interactions and contributes to our understanding of the role of Aβ peptides as copper chelators in healthy and diseased brains.
biochemistry & molecular biology,chemistry, inorganic & nuclear
-
Beta-Amyloid and Its Asp7 Isoform: Morphological and Aggregation Properties and Effects of Intracerebroventricular Administration
Valeriya Ushakova,Yana Zorkina,Olga Abramova,Regina Kuanaeva,Evgeny Barykin,Alexander Vaneev,Roman Timoshenko,Peter Gorelkin,Alexander Erofeev,Eugene Zubkov,Marat Valikhov,Olga Gurina,Vladimir Mitkevich,Vladimir Chekhonin,Anna Morozova
DOI: https://doi.org/10.3390/brainsci14101042
IF: 3.333
2024-10-22
Brain Sciences
Abstract:Background/Objectives: One of the hallmarks of Alzheimer's disease (AD) is the accumulation of aggregated beta-amyloid (Aβ) protein in the form of senile plaques within brain tissue. Senile plaques contain various post-translational modifications of Aβ, including prevalent isomerization of Asp7 residue. The Asp7 isomer has been shown to exhibit increased neurotoxicity and induce amyloidogenesis in brain tissue of transgenic mice. The toxicity of Aβ peptides may be partly mediated by their structure and morphology. In this respect, in this study we analyzed the structural and aggregation characteristics of the Asp7 isoform of Aβ42 and compared them to those of synthetic Aβ42. We also investigated the effects of intracerebroventricular (i.c.v.) administration of these peptides, a method often used to induce AD-like symptoms in rodent models. Methods: Atomic force microscopy (AFM) was conducted to compare the morphological and aggregation properties of Aβ42 and Asp7 iso-Aβ42. The effects of i.c.v. stereotaxic administration of the proteins were assessed via behavioral analysis and reactive oxygen species (ROS) estimation in vivo using a scanning ion-conductance microscope with a confocal module. Results: AFM measurements revealed structural differences between the two peptides, most notably in their soluble toxic oligomeric forms. The i.c.v. administration of Asp7 iso-Aβ42 induced spatial memory deficits in rats and elevated oxidative stress levels in vivo, suggesting a potential of ROS in the pathogenic mechanism of the peptide. Conclusions: The findings support the further investigation of Asp7 iso-Aβ42 in translational research on AD and suggest its involvement in neurodegenerative processes.
neurosciences
-
Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology
HAI LIN,RAJINDER BHATIA,RATNESHWAR LAL
DOI: https://doi.org/10.1096/fj.01-0377com
2001-11-01
The FASEB Journal
Abstract:Amyloid beta protein (AbetaP) is the major constituent of senile plaques associated with Alzheimer's disease (AD). However, its mechanistic role in AD pathogenesis is poorly understood. Globular and nonfibrillar AbetaPs are continuously released during normal metabolism. Using techniques of atomic force microscopy, laser confocal microscopy, electrical recording, and biochemical assays, we have examined the molecular conformations of reconstituted globular AbetaPs as well as their real-time and acute effects on neuritic degeneration. Atomic force microscopy (AFM) of AbetaP1-42 shows globular structures that do not form fibers in physiological-buffered solution for up to 8 h of continuous imaging. AFM of AbetaP1-42 reconstituted in a planar lipid bilayer reveals multimeric channel-like structures. Consistent with these AFM resolved channel-like structures, biochemical analysis demonstrates that predominantly monomeric AbetaPs in solution form stable tetramers and hexamers after incorporation into lipid membranes. Electrophysiological recordings demonstrate the presence of multiple single channel currents of different sizes. At the cellular level, AbetaP1-42 allows calcium uptake and induces neuritic abnormality in a dose- and time-dependent fashion. At physiological nanomolar concentrations, rapid neuritic degeneration was observed within minutes; at micromolar concentrations, neuronal death was observed within 3-4 h. These effects are prevented by zinc (an AbetaP channel blocker) and by the removal of extracellular calcium, but are not prevented by antagonists of putative AbetaP cell surface receptors. Thus, AbetaP channels may provide a direct pathway for calcium-dependent AbetaP toxicity in AD.
cell biology,biochemistry & molecular biology,biology
-
Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease
Yona Levites,Eric B Dammer,Yong Ran,Wangchen Tsering,Duc Duong,Measho Abreha,Joshna Gadhavi,Kiara Lolo,Jorge Trejo-Lopez,Jennifer L Phillips,Andrea Iturbe,Aya Erqiuzi,Brenda Dawn Moore,Danny Ryu,Aditya Natu,Kristy D Dillon,Jose Torrellas,Corey Moran,Thomas B Ladd,Kazi Farhana Afroz,Tariful Islam,Jaishree Jagirdar,Cory C Funk,Max Robinson,David R Borchelt,Nilufer Ertekin-Taner,Jeffrey W Kelly,Frank L Heppner,Erik Cb Johnson,Karen McFarland,Allan L Levey,Stefan Prokop,Nicholas T Seyfried,Todd E Golde
DOI: https://doi.org/10.1101/2023.11.29.568318
2023-12-07
bioRxiv
Abstract:We report a highly significant correlation in brain proteome changes between Alzheimers disease (AD) and CRND8 APP695NL/F transgenic mice. However, integrating protein changes observed in the CRND8 mice with co-expression networks derived from human AD, reveals both conserved and divergent module changes. For the most highly conserved module (M42, matrisome) we find many proteins accumulate in plaques, cerebrovascular amyloid (CAA), dystrophic processes, or a combination thereof. Overexpression of two M42 proteins, midkine (Mdk) and pleiotrophin (PTN), in CRND8 mice brains leads to increased accumulation of A β ; in plaques and in CAA; further, recombinant MDK and PTN enhance A β ; aggregation into amyloid. Multiple M42 proteins, annotated as heparan sulfate binding proteins, bind to fibrillar A β 42 and a non-human amyloid fibril in vitro. Supporting this binding data, MDK and PTN co-accumulate with transthyretin (TTR) amyloid in the heart and islet amyloid polypeptide (IAPP) amyloid in the pancreas. Our findings establish several critical insights. Proteomic changes in modules observed in human AD brains define an A β ; amyloid responsome that is well conserved from mouse model to human. Further, distinct amyloid structures may serve as scaffolds, facilitating the co-accumulation of proteins with signaling functions. We hypothesize that this co-accumulation may contribute to downstream pathological sequalae. Overall, this contextualized understanding of proteomic changes and their interplay with amyloid deposition provides valuable insights into the complexity of AD pathogenesis and potential biomarkers and therapeutic targets.
-
An N-terminal acidic β-sheet domain is responsible for the metal-accumulation properties of amyloid-β protofibrils: a molecular dynamics study
Carlos Z Gómez-Castro,Liliana Quintanar,Alberto Vela
DOI: https://doi.org/10.1007/s00775-024-02061-1
Abstract:The influence of metal ions on the structure of amyloid- β (Aβ) protofibril models was studied through molecular dynamics to explore the molecular mechanisms underlying metal-induced Aβ aggregation relevant in Alzheimer's disease (AD). The models included 36-, 48-, and 188-mers of the Aβ42 sequence and two disease-modifying variants. Primary structural effects were observed at the N-terminal domain, as it became susceptible to the presence of cations. Specially when β-sheets predominate, this motif orients N-terminal acidic residues toward one single face of the β-sheet, resulting in the formation of an acidic region that attracts cations from the media and promotes the folding of the N-terminal region, with implications in amyloid aggregation. The molecular phenotype of the protofibril models based on Aβ variants shows that the AD-causative D7N mutation promotes the formation of N-terminal β-sheets and accumulates more Zn2+, in contrast to the non-amyloidogenic rodent sequence that hinders the β-sheets and is more selective for Na+ over Zn2+ cations. It is proposed that forming an acidic β-sheet domain and accumulating cations is a plausible molecular mechanism connecting the elevated affinity and concentration of metals in Aβ fibrils to their high content of β-sheet structure at the N-terminal sequence.
-
Human Amyloid-Derived Aßcontains Tyrosine Cross-Linked Oligomers
Craig S. Atwood,Robert D. Moir,Walton D. Jones,Xudong Huang
DOI: https://doi.org/10.1016/s0197-4580(00)82237-x
IF: 5.133
2000-01-01
Neurobiology of Aging
Abstract:Amyloid fibrils are associated with many neurodegenerative diseases. It was found that amyloidogenic oligomers, not mature fibrils, are neurotoxic agents related to these diseases. Molecular mechanisms of infectivity, pathways of aggregation, and molecular structure of these oligomers remain elusive. Here, we use all-atom molecular dynamics, molecular mechanics combined with solvation analysis by statistical-mechanical, three-dimensional molecular theory of solvation (also known as 3D-RISM-KH) in a new MM-3D-RISM-KH method to study conformational stability, and association thermodynamics of small wild-type Aβ17–42 oligomers with different protonation states of Glu22, as well the E22Q (Dutch) mutants. The association free energy of small β-sheet oligomers shows near-linear trend with the dimers being thermodynamically more stable relative to the larger constructs. The linear (within statistical uncertainty) dependence of the association free energy on complex size is a consequence of the unilateral stacking of monomers in the β-sheet oligomers. The charge reduction of the wild-type Aβ17–42 oligomers upon protonation of the solvent-exposed Glu22 at acidic conditions results in lowering the association free energy compared to the wild-type oligomers at neutral pH and the E22Q mutants. The neutralization of the peptides because of the E22Q mutation only marginally affects the association free energy, with the reduction of the direct electrostatic interactions mostly compensated by the unfavorable electrostatic solvation effects. For the wild-type oligomers at acidic conditions such compensation is not complete, and the electrostatic interactions, along with the gas-phase nonpolar energetic and the overall entropic effects, contribute to the lowering of the association free energy. The differences in the association thermodynamics between the wild-type Aβ17–42 oligomers at neutral pH and the Dutch mutants, on the one hand, and the Aβ17–42 oligomers with protonated Glu22, on the other, may be explained by destabilization of the inter- and intrapeptide salt bridges between Asp23 and Lys28. Peculiarities in the conformational stability and the association thermodynamics for the different models of the Aβ17–42 oligomers are rationalized based on the analysis of the local physical interactions and the microscopic solvation structure.
-
N-terminal Domain of Amyloid-β Impacts Fibrillation and Neurotoxicity
Jing-Ming Shi,Hai-Yun Li,Hang Liu,Li Zhu,Yi-Bo Guo,Jie Pei,Hao An,Yan-Song Li,Sha-Di Li,Ze-Yu Zhang,Yi Zheng
DOI: https://doi.org/10.1021/acsomega.2c04583
IF: 4.1
2022-10-18
ACS Omega
Abstract:Alzheimer's disease is characterized by the presence of distinct amyloid-β peptide (Aβ) assemblies with diverse sizes, shapes, and toxicity. However, the primary determinants of Aβ aggregation and neurotoxicity remain unknown. Here, the N-terminal amino acid residues of Aβ42 that distinguished between humans and rats were substituted. The effects of these modifications on the ability of Aβ to aggregate and its neurotoxicity were investigated using biochemical, biophysical, and cellular techniques. The Aβ-derived diffusible ligand, protofibrils, and fibrils formed by the N-terminal mutational peptides, including Aβ42(R5G), Aβ42(Y10F), and rat Aβ42, were indistinguishable by conventional techniques such as size-exclusion chromatography, negative-staining transmission electron microscopy and silver staining, whereas the amyloid fibrillation detected by thioflavin T assay was greatly inhibited in vitro. Using circular dichroism spectroscopy, we discovered that both Aβ42 and Aβ42(Y10F) generated protofibrils and fibrils with a high proportion of parallel β-sheet structures. Furthermore, protofibrils formed by other mutant Aβ peptides and N-terminally shortened peptides were incapable of inducing neuronal death, with the exception of Aβ42 and Aβ42(Y10F). Our findings indicate that the N-terminus of Aβ is important for its fibrillation and neurotoxicity.
chemistry, multidisciplinary